Browse CATs

Browse CATs  internal medicine  cardiology  congestive heart failure

Diagnosis Economics Harm/ aetiology Prognosis Therapy ACE inhibitors Beta-blockers Diuretics Non-invasive ventilation Other drugs

Heart failure no clear effect of high-dose enalapril on death or hospitalisation Level of evidence 1b- Expiry Date November 2003 Heart failure high dose lisinopril reduced death and hospitalisation compared with low dose Level of evidence 1b Expiry Date November 2003 Heart failure losartan causes fewer withdrawals than captopril without clearly reducing mortality or hospital admissions in elderly patients Level of evidence 1b Expiry Date January 2004 Heart failure no clear benefit from adding candesartan to enalapril. Level of evidence 1b- Expiry Date February 2004 Heart failure ACE inhibitors, nitrates and alpha-antagonists improve function Level of evidence 1a Expiry Date October 2003 Heart failure ACE inhibitors reduce death and hospitalisation. Level of evidence 1a Expiry Date October 2003 Heart failure enalapril had no clear effect. Level of evidence 1b- Expiry Date October 2003 Heart failure captopril improved acute pulmonary oedema Level of evidence 1b- Expiry Date October 2003 Heart failure ACE inhibitors improve survival and lower hospitalisation rates. Level of evidence 1a Expiry Date July 2003 Heart failure a first dose of enalapril caused a small fall in blood pressure in elderly patients. Level of evidence 1b Expiry Date November 2003